D.E. Shaw & Co Portfolio holdings
D. E. Shaw & Co., L.P., founded in 1988 by David E. Shaw, a former Columbia University computer science professor, is a New York City-based global investment management firm renowned for pioneering quantitative investing, managing over $70 billion in assets as of late 2024. Starting with $28 million from Paloma Partners and private investors, the firm employs sophisticated mathematical models and proprietary algorithms—initially developed by a team of scientists and programmers—to exploit market anomalies across public and private markets, including equities, fixed income, and alternatives. Headquartered above a Greenwich Village bookstore in its early days, it now boasts over 2,500 employees across offices in North America, Europe, and Asia, led by a seven-member Executive Committee since Shaw stepped back in 2001 to focus on D. E. Shaw Research. Despite setbacks like the 1998 Russia debt crisis and the 2008 financial downturn, the firm has maintained a reputation for analytical rigor, risk management, and innovation, balancing its computational roots with discretionary strategies.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Broadcom
AVGO
|
+$1.2B |
| 2 |
Boston Scientific
BSX
|
+$1.05B |
| 3 |
Alphabet (Google) Class A
GOOGL
|
+$934M |
| 4 |
Alphabet (Google) Class C
GOOG
|
+$924M |
| 5 |
JPMorgan Chase
JPM
|
+$922M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$3.2B |
| 2 |
NVIDIA
NVDA
|
+$1.58B |
| 3 |
Palantir
PLTR
|
+$901M |
| 4 |
Netflix
NFLX
|
+$883M |
| 5 |
iShares Core S&P 500 ETF
IVV
|
+$805M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 30.42% |
| 2 | Technology | 18.55% |
| 3 | Consumer Discretionary | 8.97% |
| 4 | Financials | 8.5% |
| 5 | Healthcare | 8.44% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
1226
CMS Energy
CMS
$21B
| $15.8M | 0.01% |
203,828
+103,922
| +104% | +$7.71M |
2019 Q3
26 quarters
|
|
1227
Madrigal Pharmaceuticals
MDGL
$10.6B
| $15.8M | 0.01% |
30,139
-58,415
| -66% | -$27.9M |
2024 Q4
5 quarters
|
|
1228
Vermilion Energy
VET
$1.9B
| $15.7M | 0.01% |
1,139,234
+836,083
| +276% | +$8.86M |
2024 Q4
5 quarters
|
|
1229
Ligand Pharmaceuticals
LGND
$5.88B
| $15.7M | 0.01% |
78,428
+41,877
| +115% | +$8.29M |
2025 Q2
3 quarters
|
|
1230
CALL
Walt Disney
DIS
$188B
| $15.6M | 0.01% |
162,100
-248,200
| -60% | -$26.2M |
2018 Q3
30 quarters
|
|
1231
Liberty Global Class A
LBTYA
$2.79B
| $15.6M | 0.01% |
1,292,117
+819,543
| +173% | +$9.54M |
2022 Q1
16 quarters
|
|
1232
CALL
Madison Square Garden
MSGS
$9.73B
| $15.6M | 0.01% |
48,500
+38,500
| +385% | +$11.5M |
2025 Q4
1 quarter
|
|
1233
HEICO Corp
HEI
$41.7B
| $15.6M | 0.01% |
56,794
-148,341
| -72% | -$47.8M |
2018 Q4
29 quarters
|
|
1234
Toyota
TM
$222B
| $15.6M | 0.01% |
+75,537
| New | +$17.1M |
2026 Q1
0 quarters
|
|
1235
Ambev
ABEV
$50.1B
| $15.5M | 0.01% |
5,310,370
+377,351
| +8% | +$1.08M |
2024 Q1
8 quarters
|
|
1236
FIGS
FIGS
$3.1B
| $15.5M | 0.01% |
1,048,907
-247,079
| -19% | -$3.17M |
2025 Q3
2 quarters
|
|
1237
Lyft
LYFT
$6.24B
| $15.5M | 0.01% |
1,164,374
-388,943
| -25% | -$6.02M |
2020 Q1
24 quarters
|
|
1238
DELISTED
Theravance Biopharma
TBPH
| $15.5M | 0.01% |
954,042
-305,899
| -24% | -$5.41M |
2021 Q3
18 quarters
|
|
1239
Mirum Pharmaceuticals
MIRM
$5.19B
| $15.5M | 0.01% |
167,489
-780,672
| -82% | -$73.4M |
2024 Q4
5 quarters
|
|
1240
Ouster
OUST
$2.3B
| $15.5M | 0.01% |
842,089
-10,317
| -1% | -$225K |
2023 Q4
9 quarters
|
|
1241
Ezcorp Inc
EZPW
$2.01B
| $15.5M | 0.01% |
609,392
+50,640
| +9% | +$1.21M |
2015 Q4
41 quarters
|
|
1242
Ingram Micro Holding
INGM
$6.24B
| $15.4M | 0.01% |
662,473
+619,915
| +1,457% | +$13.5M |
2025 Q3
2 quarters
|
|
1243
Grab
GRAB
$11.9B
| $15.4M | 0.01% |
4,217,713
-20,699,811
| -83% | -$87.8M |
2023 Q4
9 quarters
|
|
1244
GP-Act III Acquisition Corp
GPAT
$178M
| $15.4M | 0.01% |
1,423,125
| – | – |
2024 Q3
6 quarters
|
|
1245
Janus Living Inc
JAN
$6.79B
| $15.4M | 0.01% |
+653,500
| New | +$15.3M |
2026 Q1
0 quarters
|
|
1246
DELISTED
Tri Pointe Homes
TPH
| $15.4M | 0.01% |
329,123
-1,000,040
| -75% | -$40.7M |
2019 Q2
27 quarters
|
|
1247
Adtran
ADTN
$541M
| $15.3M | 0.01% |
1,218,969
+20,196
| +2% | +$205K |
2025 Q3
2 quarters
|
|
1248
PUT
Celsius Holdings
CELH
$6.87B
| $15.3M | 0.01% |
431,400
-607,200
| -58% | -$28.8M |
2023 Q2
11 quarters
|
|
1249
CALL
Whirlpool
WHR
$1.8B
| $15.2M | 0.01% |
282,800
+24,700
| +10% | +$1.81M |
2018 Q2
31 quarters
|
|
1250
CALL
Quanta Services
PWR
$99.3B
| $15.2M | 0.01% |
27,700
-16,700
| -38% | -$8.6M |
2023 Q1
12 quarters
|
|
Similar funds
D.E. Shaw & Co's Q1 2026 Portfolio in Review
As of Q1 2026, D.E. Shaw & Co held 5,226 positions worth $166B, down 8.8% from $182B the previous quarter. Its ten largest holdings account for 11% of the portfolio.
D.E. Shaw & Co withdrew a net $5.92B in Q1 2026, closing 756 positions and reducing 1,922 holdings. Its most notable exit was iShares Core S&P 500 ETF, an estimated $805M position sold in full.
By sector, the portfolio is most concentrated in Miscellaneous at 30% of assets, down from 36% a quarter earlier, followed by Technology and Consumer Discretionary.
Against the trend, D.E. Shaw & Co opened a new position in Venture Global Inc worth $211M.
- D.E. Shaw & Co's largest Q1 2026 buy was Venture Global Inc: 13,410,074 shares worth $211M.
- D.E. Shaw & Co added most to Broadcom in Q1 2026, an estimated $1.2B increase.
- D.E. Shaw & Co's biggest Q1 2026 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $3.2B.
- D.E. Shaw & Co fully exited iShares Core S&P 500 ETF in Q1 2026, selling an estimated $805M.
- D.E. Shaw & Co's ten largest holdings make up 11% of its $166B portfolio in Q1 2026.
- D.E. Shaw & Co opened 685 new positions and closed 756 in Q1 2026.
- D.E. Shaw & Co's portfolio value fell 8.8% quarter-over-quarter to $166B.
Based on D.E. Shaw & Co's 13F filing for Q1 2026, filed 15 May 2026.